Neurodegenerative processes in Alzheimer’’s disease: an overview of pathogenesis with strategic biomarker potential

Author： Rothenberg Kasia Gustaw   Siedlak Sandra L   Lee Hyoung-gon   Zhu Xiongwei   Perry George   Smith Mark A  

Publisher： Future Medicine

ISSN： 1479-6708

Source： Future Neurology, Vol.6, Iss.2, 2011-03, pp. : 173-185

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biomarker Research of Preclinical Alzheimer’s Disease and MCI Based on Neuroimage Techniques

By  

Neuroscience and Biomedical Engineering, Vol. 1, Iss. 2, 2013-09 ,pp. : 92-101

Bentham Science Publishers

Access to resources Recommend Favorite

Cholesterol efflux as a critical component of Alzheimer’s disease pathogenesis

By Rebeck G.  

Journal of Molecular Neuroscience, Vol. 23, Iss. 3, 2004-10 ,pp. : 219-224

Humana Press, Inc

Access to resources Recommend Favorite

Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer’s disease

By Glabe Charles  

Journal of Molecular Neuroscience, Vol. 17, Iss. 2, 2001-10 ,pp. : 137-145

Humana Press, Inc

Access to resources Recommend Favorite

The Phosphoinositide Signal Transduction Pathway in the Pathogenesis of Alzheimer’s Disease

By  

Current Alzheimer Research, Vol. 15, Iss. 4, 2018-02 ,pp. : 355-362

Bentham Science Publishers

Access to resources Recommend Favorite

Tetrahydrobiopterin Availability in Parkinson’s and Alzheimer’s Disease; Potential Pathogenic Mechanisms

By Foxton Richard   Land John   Heales Simon  

Neurochemical Research, Vol. 32, Iss. 4-5, 2007-04 ,pp. : 751-756

Springer Publishing Company

Access to resources Recommend Favorite